Skip to main content
. Author manuscript; available in PMC: 2021 Feb 9.
Published in final edited form as: J Porphyr Phthalocyanines. 2019 Dec;23(11-12):1229–1240. doi: 10.1142/s1088424619300180

Fig. 1.

Fig. 1

Schematic representation of molVTP and of the different targeting moieties that have been investigated to selectively target PS to the tumor vasculature, for improving selectivity and efficacy of cancer treatment: (a) small peptide, (b) affibody, (c) single chain variable fragment (scFv), (d) antigen-binding fragment (Fab), (e) small immunoprotein (SIP), (f) antibody (IgG), and (g) nanocarrier systems